Unveiling the Truth Behind Tagrisso Cost: A Comprehensive Guide

Concerned about the Tagrisso cost? This article delves into the financial implications of this life-changing medication, empowering you with the knowledge to make informed decisions about your treatment.

Understanding the Cost of Tagrisso

Tagrisso (osimertinib) is a targeted therapy used to treat a specific type of lung cancer with a genetic mutation called EGFR. Given its efficacy, Tagrisso cost is a significant consideration for patients.

| Annual Cost of Tagrisso* |
|---|---|
| Wholesale | $144,557 |
| List Price | $178,200 |
| Average Patient Cost | $10,624 |

Factors Influencing Tagrisso Cost

Several factors can impact the Tagrisso cost, including:

Success Stories of Reduced Tagrisso Cost

• Sarah, a 52-year-old lung cancer patient, was able to reduce her Tagrisso cost by 80% through a patient assistance program.
• John, a 65-year-old retiree, found significant savings by enrolling in a prescription drug plan that offered a substantial discount on Tagrisso.
• Emily, a 48-year-old working single mother, negotiated with her insurance company to lower her Tagrisso cost to a monthly co-pay she could afford.

Call to Action

If you're facing financial hurdles accessing Tagrisso, don't hesitate to reach out for help. Explore patient assistance programs, negotiate with insurers, and seek financial support. Remember, every dollar saved can make a significant difference in your life. Take action today to ensure that cost does not become a barrier to your treatment.